Indices end near records; Sensex gains 529 pts; RIL up 2.5%, Infy dips 1%

Markets will remain shut on Friday on account of Christmas.

9:26 AM

Aurobindo Pharma up around a per cent

>> The company has signed exclusive agreement with COVAXX to develop & commercialise COVID vaccine UB-612 for India & UNICEF

9:25 AM

ITDC leaps over 13% on divestment buzz

9:24 AM

BEML hits Rs 1,000-mark in intra-day deals

9:23 AM

Vedanta surges over 6% post block deal

>> Promoters of Vedanta Limited plan to launch an offer to qualified institutional buyers (QIBs) to buy up to 4.98 per cent stake in the India-listed base metals to crude oil producer through accelerated bookbuild purchase of equity shares (block deals) on Thursday.

9:22 AM

Bharti Airtel up 2% post Trai data

>> Trai data released on Wednesday that showed Bharti Airtel pipped Reliace Jio in mobile customer addition in October. This is the second consecutive month when Airtel added highest number of subscribers with 3.67 million new customers

9:21 AM

Sectoral trends on NSE:: Metal, PSB stocks gain traction

9:20 AM

Sensex Heatmap :: IT stocks take a breather; Infy down 1% at open

9:19 AM

Opening Bell :: Nifty holds 13,650

9:17 AM

Opening Bell :: Sensex gains over 200 pts

9:16 AM

News Flash | Vedanta has 24.9 lakh shares change hands in pre-market trade: Agencies

Promoters of Vedanta Limited plan to launch an offer to qualified institutional buyers (QIBs) to buy up to 4.98 per cent stake in the India-listed base metals to crude oil producer through accelerated bookbuild purchase of equity shares (block deals) on Thursday.

9:10 AM

Commodity Heatmap

9:06 AM

Top gainers and losers on S&P BSE Sensex at Pre-open

9:06 AM

Markets at Pre-open

9:05 AM

Markets at Pre-open

9:02 AM

BROKERAGE VIEW :: Antique Broking on ACC and Ambuja Cement

ACC | CMP: Rs 1580 | TP: Rs 1,980 | Reco: Buy

Ambuja | CMP: Rs 237 | TP: 295 | Reco: Buy

In the last month, ACC/Ambuja price performance underperformed peers, with stocks falling 8-8.5% vs peers Ultratech/Shree Cement move of +3%/-2% - largely attributable to speculation around the anticipated change in fees to parent. With this overhang behind, the investors' focus would again shift to core business and earnings of the two Companies. While there is softness in Industry volumes and pricing in December, we expect Utilization & pricing to pick up in 4Q with the setting in of busy construction season. Showcase of cost savings and recent improvement in profit trends for both ACC and Ambuja have driven traction in the stock. We continue to maintain BUY on both ACC (PT: INR1,980) and Ambuja (PT: INR295), with preference for Ambuja.